A research team has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

Investigators assessed whether intravesical BCG is necessary for patients with high-grade T1 nonmuscle-invasive bladder cancer who have unremarkable histology on the second transurethral resection.

Researchers at City of Hope now understand why taking an investigational white button mushroom supplement shows promise in ...

Teleflex Incorporated (NYSE: TFX) has announced the enrollment of the first patient in a new clinical study focused on the ...

About Barrigel™ Rectal Spacer Barrigel ™ rectal spacer is the first and only hyaluronic acid rectal spacer that separates the prostate from the rectum to protect the rectum during radiation therapy ...

Men could benefit from fewer unnecessary treatments and reduced anxiety if their doctors stopped calling certain changes in the prostate “cancer,” according to prominent UC San Francisco prostate ...

If you have any of these signs, you should see your doctor as soon as possible. Learn more about prostate cancer from the National Cancer Institute. Huntsman Cancer Institute’s Urologic Cancers ...

The new therapy combines two existing cancer drugs, enzalutamide and talazoparib. Enzalutamide, known by its brand name XTANDI, has been used as a treatment for metastatic castration-resistant ...

This approach aims to prevent both overtreatment and undertreatment in localized prostate cancer, facilitating shared decision making. The MMAI risk classification system reclassified 42% of patients ...